ArticleCell stress & chaperones2026
Acupuncture suppresses the endoplasmic reticulum stress-c-Jun N-terminal kinase pathway to inhibit chondrocyte apoptosis and attenuate knee osteoarthritis.
Article in Cell stress & chaperones, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKnee osteoarthritis (KOA) is a degenerative joint disease characterized by progressive cartilage degradation, in which chondrocyte apoptosis plays a pivotal role. Acupuncture is widely used for KOA management, but its underlying molecular mechanisms remain poorly understood. Endoplasmic reticulum (ER) stress-induced apoptosis via the c-Jun N-terminal kinase (JNK) pathway is a critical driver of chondrocyte death in KOA. This study aimed to investigate whether acupuncture exerts its chondroprotective effects by modulating the ER stress-JNK signaling axis.
methodsA rat model of KOA was established by joint immobilization. Fifty rats were randomly assigned to five groups: Normal, Model, Model+Acupuncture (Acu), Model+ Acu+Anisomycin (JNK activator), and Model+SP600125 (JNK inhibitor). The therapeutic efficacy of a 4-week acupuncture regimen was evaluated through behavioral scores, radiographic imaging, and histological analysis. Unbiased RNA sequencing was performed to identify key signaling pathways. The mechanism was further validated through TUNEL staining, transmission electron microscopy (TEM), Western blot, RT-qPCR, immunofluorescence, and ELISA.
resultsUnbiased transcriptomic analysis identified the ER stress and MAPK/JNK signaling pathways as key targets of acupuncture. Acupuncture significantly improved joint function, alleviated cartilage degradation, and preserved proteoglycan content in KOA rats. Mechanistically, acupuncture suppressed the expression of the ER stress marker IRE1α, inhibited the phosphorylation of JNK, and consequently downregulated the pro-apoptotic Bax/Bcl-2 ratio and Caspase-3 expression. This led to a marked decrease in chondrocyte apoptosis and restoration of ER homeostasis, as confirmed by TUNEL and TEM. Crucially, the anti-apoptotic effects of acupuncture were significantly counteracted by the JNK activator Anisomycin. In addition, acupuncture remodels the systemic inflammatory network by suppressing the production of proinflammatory cytokines IL-1β and TNF-α, which triggers a compensatory upregulation of the anti-inflammatory mediator IL-10.
conclusionOur findings demonstrate for the first time that acupuncture ameliorates KOA by inhibiting chondrocyte apoptosis via suppression of the ER stress-JNK signaling pathway. This study provides a novel and robust mechanistic rationale for the clinical application of acupuncture and highlights the ER stress-JNK axis as a promising therapeutic target for KOA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.